Search Results - "Drost, Rinske"
-
1
Loss of 53BP1 causes PARP inhibitor resistance in Brca1-mutated mouse mammary tumors
Published in Cancer discovery (01-01-2013)“…Inhibition of PARP is a promising therapeutic strategy for homologous recombination-deficient tumors, such as BRCA1-associated cancers. We previously reported…”
Get more information
Journal Article -
2
BRCA1 RING Function Is Essential for Tumor Suppression but Dispensable for Therapy Resistance
Published in Cancer cell (13-12-2011)“…Hereditary breast cancers are frequently caused by germline BRCA1 mutations. The BRCA1 C61G mutation in the BRCA1 RING domain is a common pathogenic missense…”
Get full text
Journal Article -
3
Selective Inhibition of BRCA2-Deficient Mammary Tumor Cell Growth by AZD2281 and Cisplatin
Published in Clinical cancer research (15-06-2008)“…Purpose: To assess efficacy of the novel, selective poly(ADP-ribose) polymerase-1 (PARP-1) inhibitor AZD2281 against newly established BRCA2-deficient mouse…”
Get full text
Journal Article -
4
Selected Alkylating Agents Can Overcome Drug Tolerance of G0-like Tumor Cells and Eradicate BRCA1-Deficient Mammary Tumors in Mice
Published in Clinical cancer research (15-11-2017)“…Abstract Purpose: We aimed to characterize and target drug-tolerant BRCA1-deficient tumor cells that cause residual disease and subsequent tumor relapse…”
Get full text
Journal Article -
5
Challenging Future Generations: A Qualitative Study of Students' Attitudes toward the Transition to Animal-Free Innovations in Education and Research
Published in Animals (Basel) (24-01-2023)“…In 2016, the Dutch government declared its commitment to phasing out animal experiments by 2025. Although a high number of animal experiments are still…”
Get full text
Journal Article -
6
Palb2 synergizes with Trp53 to suppress mammary tumor formation in a model of inherited breast cancer
Published in Proceedings of the National Academy of Sciences - PNAS (21-05-2013)“…Germ-line mutations in PALB2 lead to a familial predisposition to breast and pancreatic cancer or to Fanconi Anemia subtype N. PALB2 performs its tumor…”
Get full text
Journal Article -
7
BRCA1185delAG tumors may acquire therapy resistance through expression of RING-less BRCA1
Published in The Journal of clinical investigation (01-08-2016)Get full text
Journal Article -
8
BRCA1185delAG tumors may acquire therapy resistance through expression of RING-less BRCA1
Published in The Journal of clinical investigation (01-08-2016)“…Heterozygous germline mutations in breast cancer 1 (BRCA1) strongly predispose women to breast cancer. BRCA1 plays an important role in DNA double-strand break…”
Get full text
Journal Article -
9
Distinct cardiotoxic effects by venoms of a spitting cobra (Naja pallida) and a rattlesnake (Crotalus atrox) revealed using an ex vivo Langendorff heart model
Published in Toxicon (Oxford) (01-03-2024)“…Here we describe the acute myocardial effects of an elapid (red spitting cobra, Naja pallida) and a viper (western diamondback rattlesnake, Crotalus atrox)…”
Get full text
Journal Article -
10
Selected Alkylating Agents Can Overcome Drug Tolerance of G 0 -like Tumor Cells and Eradicate BRCA1-Deficient Mammary Tumors in Mice
Published in Clinical cancer research (15-11-2017)“…We aimed to characterize and target drug-tolerant BRCA1-deficient tumor cells that cause residual disease and subsequent tumor relapse. We studied responses to…”
Get full text
Journal Article -
11
A high-throughput functional complementation assay for classification of BRCA1 missense variants
Published in Cancer discovery (01-10-2013)“…Mutations in BRCA1 and BRCA2 account for the majority of hereditary breast and ovarian cancers, and therefore sequence analysis of both genes is routinely…”
Get more information
Journal Article -
12
BRCA1-deficient mammary tumor cells are dependent on EZH2 expression and sensitive to Polycomb Repressive Complex 2-inhibitor 3-deazaneplanocin A
Published in Breast cancer research : BCR (01-01-2009)“…Treatment of breast cancer is becoming more individualized with the recognition of tumor subgroups that respond differently to available therapies. Breast…”
Get full text
Journal Article -
13
Loss of p53 partially rescues embryonic development of Palb2 knockout mice but does not foster haploinsufficiency of Palb2 in tumour suppression
Published in The Journal of pathology (01-05-2011)“…PALB2 interacts with BRCA1 and BRCA2 in supercomplexes involved in DNA repair via homologous recombination. Heterozygous germline mutations in PALB2 confer a…”
Get full text
Journal Article -
14
BRCA1^sup 185delAG^ tumors may acquire therapy resistance through expression of RING-less BRCA1
Published in The Journal of clinical investigation (01-08-2016)“…Heterozygous germline mutations in breast cancer 1 (BRCA1) strongly predispose women to breast cancer. BRCA1 plays an important role in DNA double-strand break…”
Get full text
Journal Article -
15
tumors may acquire therapy resistance through expression of RING-less BRCA1
Published in The Journal of clinical investigation (01-08-2016)“…Heterozygous germline mutations in breast cancer 1 (BRCA1) strongly predispose women to breast cancer. BRCA1 plays an important role in DNA double-strand break…”
Get full text
Journal Article -
16
BRCA1 super( 185delAG) tumors may acquire therapy resistance through expression of RING-less BRCA1
Published in The Journal of clinical investigation (01-08-2016)“…Heterozygous germline mutations in breast cancer 1 (BRCA1) strongly predispose women to breast cancer. BRCA1 plays an important role in DNA double-strand break…”
Get full text
Journal Article -
17
Each of the four intracellular cysteines of CD36 is essential for insulin- or AMP-activated protein kinase-induced CD36 translocation
Published in Archives of physiology and biochemistry (01-02-2014)“…Abstract Stimulation of cellular fatty acid uptake by induction of insulin signalling or AMP-kinase (AMPK) activation is due to translocation of the fatty…”
Get full text
Journal Article -
18
Selective Inhibition of BRCA2-Deficient Mammary Tumor Cell Growth byAZD2281 and Cisplatin
Published in Clinical cancer research (2008)Get full text
Journal Article